Confirmed Speakers

Levi Garraway M.D., Ph.D.
Department of Medical Oncology, Dana-Farber Cancer Institute Associate Physician, Brigham and Women's Hospital


Dr. Levi Garraway is an Assistant Professor of Medicine in the Department of Medical Oncology at the Dana-Farber Cancer Institute, Harvard Medical School. Dr. Garraway is also a faculty member of Dana-Farber’s Center for Cancer Genome Discovery and an Associate Member of the Broad Institute of Harvard and MIT, where he is co-Director of Cancer Genome Analysis in the Broad Cancer Program.

Dr. Garraway received his A.B. in Biochemical Sciences from Harvard College in 1990, and his M.D. and Ph.D. degrees from Harvard Medical School in 1999. Thereafter, he completed his internship and residency in Internal Medicine at the Massachusetts General Hospital, where he also served as Medical Chief Resident in 2003. He received fellowship training in Medical Oncology at the Dana-Farber Cancer Institute. Dr. Garraway leads an investigative team in cancer genomics at Dana-Farber and the Broad Institute.

Dr. Garraway has been the recipient of several awards and honors, including the Minority Scholar Award from the American Association of Cancer Research, the Partners in Excellence Award from the Massachusetts General Hospital, and the Career Award in the Biomedical Sciences from the Burroughs-Wellcome Fund. In the fall of 2007, Dr. Garraway was awarded one of the first prestigious New Innovator Awards from the National Institutes of Health, worth $1.5 million over five years. The Innovator Awards were given to the top 29 scientists from over 2200 applicants nationwide.

Back to Confirmed Speakers

"The Partnering for Cures conference provides a unique opportunity for leaders from business, philanthropy and nonprofits to come together to build partnerships to address the world's most challenging diseases. This type of cross-sector collaboration is critical to spurring innovation, mobilizing funds and shortening timelines to develop urgently needed drugs, vaccines and diagnostics for the prevention and treatment of high impact diseases."

- Dr. Seth Berkley, President & CEO, The International AIDS Vaccine Initiative

 
 
 
©2009 by Partnering for Cures  Terms Of Use  |  Privacy Statement